Home/Filings/4/0000769993-04-000397
4//SEC Filing

BRIDGE STREET FUND 1995 LP 4

Accession 0000769993-04-000397

CIK 0001013243other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 6:27 PM ET

Size

25.6 KB

Accession

0000769993-04-000397

Insider Transaction Report

Form 4
Period: 2004-06-16
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
Transactions
  • Award

    Stock Option (right to buy)

    2004-06-16+5,0005,000 total(indirect: See Footnote)
    Exercise: $4.12Exp: 2014-06-16Common Stock (5,000 underlying)
Holdings
  • Stock Option (right to buy)

    (indirect: See Footnote)
    Exercise: $17.98Exp: 2013-11-20Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: See Footnotes)
    3,415,602
Footnotes (7)
  • [F1]This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Adv isors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs) and The Goldman Sachs Group, Inc. ("GS Group", together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate.
  • [F2]Goldman Sachs beneficially owns directly and GS Group may be deemed to beneficially own indirectly 355 shares of aaiPharma Inc. common stock, $0.001 par value per share ("Common Stock"). Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through the Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of its pecuniary interest therein.
  • [F3]GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directl y and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge.
  • [F4]Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities.
  • [F5]These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are immediately exercisable.
  • [F6]These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, w hich was November 20, 2003, and 33.4% on the third anniversary of the grant date.
  • [F7]These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, w hich was August 2, 2002, and 33.4% on the third anniversary of the grant date.

Issuer

AAIPHARMA INC

CIK 0001013243

Entity typeother

Related Parties

1
  • filerCIK 0000941186

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 6:27 PM ET
Size
25.6 KB